Roy Eldor

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 7

Top Topics

Glycemic Control

Cognitive Impairment

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Eugene Merzon, Miriam Shpigelman, Shlomo Vinker, Avivit Golan Cohen, Ilan Green, Ariel Israel, T Cukierman-Yaffe, Roy Eldor
Clinical characteristics and healthcare utilisation associated with undiagnosed cognitive impairment in elderly patients with diabetes in a primary care setting: a population-based cohort study. BMJ open 14 (1) (2024)
Eugene Merzon, Miriam Shpigelman, Shlomo Vinker, Avivit Golan Cohen, Ilan Green, Ariel Israel, T Cukierman-Yaffe, Roy Eldor
Clinical characteristics and healthcare utilisation associated with undiagnosed cognitive impairment in elderly patients with diabetes in a primary care setting: a population-based cohort study. BMJ open 14 (1) (2024)
Eugene Merzon, Miriam Shpigelman, Shlomo Vinker, Avivit Golan Cohen, Ilan Green, Ariel Israel, T Cukierman-Yaffe, Roy Eldor
Clinical characteristics and healthcare utilisation associated with undiagnosed cognitive impairment in elderly patients with diabetes in a primary care setting: a population-based cohort study. BMJ open 14 (1) (2024)
Eugene Merzon, Miriam Shpigelman, Shlomo Vinker, Avivit Golan Cohen, Ilan Green, Ariel Israel, T Cukierman-Yaffe, Roy Eldor
Clinical characteristics and healthcare utilisation associated with undiagnosed cognitive impairment in elderly patients with diabetes in a primary care setting: a population-based cohort study. BMJ open 14 (1) (2024)
Roy Eldor, Bruce H Francis, Alexander Fleming, Joel Neutel, Kenneth Homer, Miriam Kidron, Julio Rosenstock
Oral insulin (ORMD-0801) in type 2 diabetes mellitus: A dose-finding 12-week randomized placebo-controlled study. Diabetes, obesity & metabolism (2022)
Roy Eldor, Joel Neutel, Kenneth Homer, Miriam Kidron
Efficacy and safety of 28-day treatment with oral insulin (ORMD-0801) in patients with type 2 diabetes: A randomized, placebo-controlled trial. Diabetes, obesity & metabolism 23 (11) (2021)
Roy Eldor, Luke Norton, Marcel Fourcaudot, Cynthia Galindo, Ralph A DeFronzo, Muhammad Abdul-Ghani
Increased lipid availability for three days reduces whole body glucose uptake, impairs muscle mitochondrial function and initiates opposing effects on PGC-1α promoter methylation in healthy subjects. PloS one 12 (12) (2017)